Several new migraine prophylactic agents are now on the market, targeting the calcitonin gene related peptide (CGRP) or CGRP receptor. This module will give an overview of the clinical pharmacology of CGRP agents and considerations for use in migraine management.
At the conclusion of this activity, participants will be better able to:
Donald Bright, MD
Staff Neurologist, VA Puget Sound Health Care System, Seattle, WA
Access presentation here: https://uwcne.net/media/2019/19122-04-Bright/19122-04-Bright_player.html